• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

11.39 -0.04 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,541,136
Open 11.43
Bid (Size) 9.200 (100)
Ask (Size) 11.75 (100)
Prev. Close 11.43
Today's Range 11.08 - 11.75
52wk Range 4.121 - 36.26
Shares Outstanding 54,769,800
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
May 26, 2026
From Olema Oncology
Via GlobeNewswire

Performance

YTD
-54.9%
-54.9%
1 Month
-15.9%
-15.9%
3 Month
-19.3%
-19.3%
6 Month
-56.6%
-56.6%
1 Year
+139.8%
+139.8%

More News

Read More
News headline image
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026
From Olema Oncology
Via GlobeNewswire
Olema Pharmaceuticals (NASDAQ:OLMA) Reports Narrower Q1 Loss, Eyes Fall Breast Cancer Data Readout ↗
May 12, 2026
Via Chartmill
Olema Pharmaceuticals Inc (NASDAQ:OLMA) Beats Q4 2025 EPS Estimates, Provides Key Pipeline Updates ↗
March 16, 2026
Via Chartmill
News headline image
Olema Oncology to Participate in Upcoming Investor Conferences
May 19, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
May 12, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
April 29, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
April 21, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
April 17, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
March 22, 2026
Via The Motley Fool
News headline image
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
March 17, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗
March 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 16, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
March 15, 2026
Via The Motley Fool
Top stock movements in today's session. ↗
March 09, 2026
Via Chartmill
News headline image
Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA
March 09, 2026
From DJS Law Group
Via Business Wire
Monday's session: top gainers and losers ↗
March 09, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
March 09, 2026
Via Chartmill
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
March 09, 2026
Via Benzinga
Topics Stocks
News headline image
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 03, 2026
From Olema Oncology
Via GlobeNewswire
News headline image
Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗
February 25, 2026
Via The Motley Fool
News headline image
Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗
February 25, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Olema Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Olema Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Olema Pharmaceuticals, Inc. - Common Stock trade on?
Olema Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock is OLMA on the Nasdaq Stock Market
What is the current price of Olema Pharmaceuticals, Inc. - Common Stock?
The current price of Olema Pharmaceuticals, Inc. - Common Stock is 11.39
When was Olema Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Olema Pharmaceuticals, Inc. - Common Stock was at 06/26/26 04:00 PM ET
What is the market capitalization of Olema Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Olema Pharmaceuticals, Inc. - Common Stock is 623.83M
How many shares of Olema Pharmaceuticals, Inc. - Common Stock are outstanding?
Olema Pharmaceuticals, Inc. - Common Stock has 624M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap